Companies ›Healthcare ›TNH.HM

TNH.HM — — Healthcare Facilities & Services

Tnh.Hm

$9 980,00

Open in Charts → Attach watcher ⌖

— —

USD

Set alert

Last 30 days

1D5D1M3M6MYTD1Y5YMax

Live price chart loads from the market-data widget.

Mcap

—

P/E

—

EV / Rev

—

Div yield

—

Op margin

-17,7 %

ROE

-5,5 %

Net margin

-18,3 %

Debt / equity

0,61

Beta

—

52w range

—

Volume

—

Day range

—

Prev close

—

Open

—

Next earnings

—

Ex-dividend

—

TR 1Y

—

About

TNH.HM operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.

Business. TNH.HM operates in the healthcare sector, primarily engaged in pharmaceuticals and healthcare facilities and services, generating revenue through the provision of healthcare-related products and services.

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

Generated · model-assisted

Sell-side consensus

SELL2 analysts

0 buy0 hold2 sell

Avg 12m price target12 065,22

Analyst recommendations

2 analysts · consensus Sell

Buy0

Hold0

Sell2

12-month price target

12 065,22

Consensus of sell-side coverage.

Upcoming events

— missing data

See all catalysts →

At a glance

Score

—

not yet scored

Valuation

—

valuation pending

Analysts→

Sell

2 analysts · indicative

Ownership

—

not yet wired

Profitability→

-5,5 %

return on equity

Quality

—

not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

No recent newsroom coverage mentioning TNH.

Sector rotation

Sector1D1Mvs mkt

Materials+2,3 %+6,6 %+1,7 %

Communication Services+2,2 %−5,5 %+1,6 %

Energy+0,6 %+3,3 %+0,0 %

Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %

Information Technology+0,6 %+6,7 %+0,0 %

Consumer Discretionary+0,4 %+7,6 %−0,2 %

Financials−0,3 %−2,8 %−0,9 %

Consumer Staples−0,4 %+2,5 %−1,0 %

Real Estate−0,7 %+10,9 %−1,3 %

Industrials−1,9 %−3,1 %−2,5 %

Utilities−1,9 %+28,2 %−2,5 %

Developing storylines

No tracked sagas currently linked to TNH.HM. Browse all sagas →

Analysis

AI analysis

Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

Opportunity

— missing data

Upcoming catalysts

Scheduled public events. Informational only — not investment advice.

Macro
Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
Macro & political
ElectionSE Swedish Election2026-09-14 · SE
ElectionUS U.S. Midterms2026-11-03 · US
ElectionFR French Legislative2027-06-01 · FR

Pre-earnings brief

— missing data

Signals & dispatch

peak dispatch · —

Composite-score breakdown

Synthesis

Business

Classification92 %

SectorHealthcare

Business sectorHealthcare Services & Equipment

IndustryHealthcare Facilities & Services

ActivityPharmaceuticals

AI synthesis

GENERATED

TNH.HM's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate level of leverage. The company's liquidity is assessed as medium, with a current ratio of 0.9, suggesting that it may struggle to meet short-term obligations with its current assets. The company's financial health is further reflected in its negative return on equity of -5.45% and a negative return on assets of -3.24%, which indicate poor profitability and asset utilization.

The company's profitability is significantly below industry standards, as evidenced by its negative operating income of -90,147,690,770.0 and a net loss of -93,131,476,740.0. These figures suggest that TNH.HM is not generating sufficient revenue to cover its operating costs and is experiencing a substantial decline in profitability. The company's gross profit of 27,950,817,790.0 is also a concern, as it indicates that the company is not effectively managing its production costs or pricing its products and services appropriately.

TNH.HM's revenue concentration is not explicitly detailed in the provided data, but the company's financial snapshot suggests a reliance on a single revenue stream or a limited number of segments. The absence of detailed segment data makes it difficult to assess the geographic exposure and diversification of the company's revenue sources. The company's growth trajectory is also concerning, as it is experiencing a significant decline in profitability and is not generating positive cash flows from operations.

The risk assessment for TNH.HM highlights several critical issues, including a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a red flag, indicating that it may need to seek additional financing to sustain its operations. The company's free cash flow of -389,891,146,050.0 and operating cash flow of -47,910,474,880.0 further underscore the financial challenges it faces.

Recent events and filings for TNH.HM do not provide specific details, but the company's financial performance and risk profile suggest that it may be under pressure to improve its operational efficiency and financial stability. The absence of analyst recommendations for strong buy or buy indicates a lack of confidence in the company's future prospects.

Key takeaways

TNH.HM is experiencing significant financial distress, as evidenced by its negative operating income and net loss.
The company's liquidity position is weak, with a current ratio below 1 and negative net cash after debt.
TNH.HM's profitability metrics are far below industry standards, indicating poor performance in managing costs and generating returns.
The company's capital structure is moderately leveraged, with a debt-to-equity ratio of 0.61.
Analysts have not issued any strong buy or buy recommendations, reflecting a lack of confidence in the company's future.
**margin_outlook_rationale**: The company's gross profit margin is low, indicating inefficiencies in production or pricing strategies.
**rd_outlook_rationale**: There is no specific information provided about the company's research and development activities or their impact on future profitability.

Bull / Bear case

analysis pipeline

— missing data

In focus — financials by report

Valuation

Market price

$9 980,00

Market cap

—

Enterprise valueⓘ

—

P/Eⓘ

—

Non-GAAP P/Eⓘ

—

EV / Revenueⓘ

—

EV / Op incomeⓘ

—

EV / OCFⓘ

—

P / Bⓘ

—

P / Tangible bookⓘ

—

Tangible book

$1.71T

Net cashⓘ

-$1.04T

Current ratioⓘ

0.9

Debt / equityⓘ

0.6

ROAⓘ

-3.2%

ROEⓘ

-5.5%

Cash conversionⓘ

51.0%

CapEx / revenueⓘ

-72.5%

SBC / revenueⓘ

—

Dilution ratioⓘ

0.0%

Revenue by segment

Business relationships

— missing data

Supply chain

— missing data

Peer comparison

— missing data

Market position

Stress test

— missing data

Predictor forecast

Next quarternear-term

Earnings · next quarterconf 45 %

EPS

Consensus EPS

14,30

Predicted surprise

+0,00

Beat probability

45 %

Analysts

Other metrics

Revenue

—

no estimate

Segment revenue

—

no estimate

Margin

—

no estimate

Segment margin

—

no estimate

as of 2026-05-10 · Earnings Surprise V1

Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.

Full fiscal year~1 year ahead

Full fiscal year · our forecast vs guidance vs consensus

Metric	Our forecast	Guidance	Consensus
EPS	—no estimate	—no estimate	14,30
Revenue	—no estimate	—no estimate	619,0B VND
Operating income	—no estimate	—no estimate	60,1B VND

Full-year consensus mean (period as reported by source) · consensus in VND. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.

Probabilistic model output — not investment advice. · generated 2026-08-04

Options

— missing data

Short squeeze

— missing data

Earnings-call key lines

— missing data

Consensus distribution

sell-side coverage

Recommendation distribution2 analysts

Strong buy0

Buy0

Hold0

Sell2

Strong sell0

12-month price target$12 065,22 · Median $12 065,22

Low $11 000,00High $13 130,43

Operating income · consensus60,1B VND

EPS surprise

−4 561,5 %

reported vs consensus · miss

Revenue surprise

−18,3 %

reported vs consensus · miss

Estimate revisions

consensus EPS · 26-week trend

— missing data

Sell-side observations

Low$11 000,00

Mean$12 065,22

Median$12 065,22

High$13 130,43

Spot$9 980,00

+20.9 %implied to mean12-month sell-side price targets · ▲ spot

Themes

— missing data

ESG

— missing data

Risk factors

Dilution riskLow

Liquidity riskMedium

Filing-based flags

Net cash is negative after subtracting total debt.

Benchmarks vs cohort

Op Margin-17,7 %Bottom quartile

Net Margin-18,3 %Bottom quartile

ROE-5,5 %Bottom quartile

Capex / Rev-72,5 %Bottom quartile

D/E0,61Below median

Cash Conv0,51Below median

Corporate actions / M&A

— missing data

FX exposure

— missing data

Comparable transactions

— missing data

Derivatives & instruments

— missing data

Actions

Set alert Open in charts

Ask Handelsavisen

— missing data

Data sources

Market data
Market data cache
Issuer disclosures
Public news
Earnings transcripts
Consensus estimates
ESG data

How metrics are computed

Dilution Ratio
(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Net Cash
cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
Capex To Revenue
capital_expenditure / revenue
Return On Equity
net_income / total_equity
Debt To Equity
(short_term_debt + long_term_debt) / total_equity
Cash Conversion Ratio
operating_cash_flow / net_income

Source documents

TNH.HM Market data — financials · 2026-05-29
TNH Hospital Group JSC Market data — analyst estimates · 2026-05-29

Ownership & reference

Insider activity

— missing data

Short positioning

— missing data

Geographic breakdown

— missing data

Listings · one canonical issuer all listings resolve to the canonical

TNH.HMCanonical

— · USD

Intel & risk

PredictorBeat prob45 %Surprise+0,00Full forecast →

peak dispatch · —

OSINT findings

Dilution riskLow

Liquidity riskMedium

Net cash is negative after subtracting total debt.

Evidence & claims

From filings & derived data

— missing data

The Thread

Everything we know, in order

2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)

The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.

Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage

Analyst recommendations

At a glance

What drives this business

News & coverage

Sector rotation

Developing storylines

Analysis

Opportunity

Upcoming catalysts

Pre-earnings brief

Signals & dispatch

Composite-score breakdown

Synthesis

Bull / Bear case

In focus — financials by report

Valuation

Revenue by segment

Market share

Business relationships

Supply chain

Peer comparison

Market position

Stress test

Predictor forecast

Options

Short squeeze

Earnings-call key lines

Consensus distribution

Estimate revisions

Sell-side observations

Themes

ESG

Risk factors

Benchmarks vs cohort

Corporate actions / M&A

FX exposure

Comparable transactions

Derivatives & instruments

Actions

Ask Handelsavisen

Ownership & reference

Insider activity

Short positioning

Geographic breakdown

Intel & risk

Evidence & claims

The Thread